Dr. Kung-Ming Jan, MD

Dr. Jan practices at Columbia University Irving Medical Center in New York, New York.

Dr. Jan's NPI, 1699752261, was assigned on December 27, 2005. Dr. Jan graduated from National Taiwan University College of Medicine in 1967. Dr. Jan holds New York license 122967.

Dr. Jan's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 305-4920.

Dr. Jan's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Jan is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors (Columbia University Irving Medical Center). Dmand AI also links Dr. Jan to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jan practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Jan's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Jan is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Jan's licenses on file in 3 states: New York, California and New Jersey.

Dmand AI lists anemia, aneurysm, atrial fibrillation and flutter, chronic diabetes, chronic hypertension, gastrointestinal bleeding, heart failure and heart valve disorders among the conditions Dr. Jan treats.

CMS data shows 1,235 Medicare services from Dr. Jan across 6 procedure codes in 2024, for 852 Medicare patients. Medicare paid $121,403 for them.

CMS counts 852 Medicare patients who saw Dr. Jan in 2024. The largest group is 75 to 84, with 305 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jan's median patient age at 65, with 55% women.

In 2024, Dr. Jan wrote 3,015 Medicare Part D claims for 241 patients. 87% of them were for generic drugs. CMS names the drug for 2,467 of them, across 56 drugs with 11 or more claims each, at $231,656 in total drug cost. In 2023, CMS named 2,377 claims across 58 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 30 out of 100 for Dr. Jan for performance year 2024, reported individually. Dr. Jan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Jan, published from 2011 to 2020. 2015 was the busiest year, with 2. The most frequent topics are Aorta, Endothelium, Vascular and Aquaporin 1. Dr. Jan has published most often in Am J Physiol Heart Circ Physiol.

CMS Open Payments shows 454 general payments to Dr. Jan from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $1,475.

Dr. Jan graduated from National Taiwan University College of Medicine in 1967.

Dr. Jan is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.